Objective: To discuss the effects of medication reconciliation in promoting the rational drug use and preventing medication errors and risks of inpatients of respiratory medicine department. Methods: The medication history and prescriptions of inpatients were collected and analyzed by clinical pharmacists using the method of retrospective medical records analysis. The medication reconciliation was performed in 95 patients hospitalized in respiratory medicine department from December 2014 to September 2015. The problems and risks of clinical irrational drug use were also explored. Results: Clinical pharmacists investigated the varieties of drugs, usage and dosage and adverse drug reactions in detail. A total of 109 cases of irrational drug use and risks of medication were found through the medication reconciliation, repeated medication accounting for 42.20%, drug omission accounting for 11.01%, drug use without indications accounting for 8.26%, adverse interaction accounting for 8.26%. 87.16% of the problems found by clinical pharmacists were recognized and adjusted by physicians. Conclusion: Medication reconciliation plays an important role in promoting rational drug use, preventing medication errors and risks, and providing a new way of pharmacy services for clinical pharmacists.
Key words
medication reconciliation;medication error;respiratory medicine department;rational drug use
{{custom_keyword}} /
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] Pourrat X,Corneau H,Floch S,et al.Communication between Community and Hospital Pharmacists:Impact on Medication Reconciliation at Admission[J].Int J Clin Pharm,2013,35(4):656-663.
[2] Institute of Medicine of the National Academies.Preventing Medication Errors[M].Washington,DC:National Academies Press,2006.
[3] 郭园林.给药差错15例分析与护理对策[J].临床合理用药杂志,2015,8(6):84-86.
[4] Giménez Manzorro á,Zoni AC,Rodríguez Rieiro C,et al.Developing a Programmefor Medication Reconciliation at the Time of Admission Intohospital[J]. Int J Clin Pharm,2011,33(4):603-609.
[5] 管凌燕,何晓静.美国药物整合制度介绍及实施情况分析[J].实用药物与临床,2013,16(8):760-762.
[6] 《中国国家处方集》编委会. 中国国家处方集:化学药品与生物制品卷[M]. 北京:人民军医出版社,2012.
[7] 卫生部合理用药专家委员会. 中国医师药师临床用药指南[M]. 1版. 重庆出版社,2009:823.
[8] 《抗菌药物临床应用指导原则》修订工作组. 抗菌药物临床应用指导原则[M]. 北京:人民军医出版社,2015.
[9] 中华医学会结核病学分会.肺结核诊断和治疗指南[J]. 中国实用乡村医生杂志,2013,20(2):7-11.
[10] 慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组. 慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2014年修订版)[J].国际呼吸杂志,2014, 34(1):1-11.
[11] 中华医学会心血管病学分会肺血管病学组. 急性肺栓塞诊断与治疗中国专家共识(2015)[J].中华心血管病杂志,2016,44(3):197-211.
[12] 中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南(2016年版)[J].中华结核和呼吸杂志,2016,39(9):1-24.
[13] 成人支气管扩张症诊治专家共识编写组. 成人支气管扩张症诊治专家共识[J]. 中华结核和呼吸杂志,2012, 35(7):485-492.
[14] 刘治军.国外临床药师药物重整工作简介[J].药品评价,2012,9(32):6-9.
[15] 张晓荧,张四喜,周微,等.肾内科临床药师在药物整合服务中的实践探索[J].药学实践杂志,2015, 33(1):88-90.
[16] "D-二聚体检测"急诊临床应用专家共识组."D-二聚体检测"急诊临床应用专家共识[J].中国急诊医学杂志,2013,22(8):1-14.
{{custom_fnGroup.title_en}}
Footnotes
{{custom_fn.content}}